CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population

Brain, Behavior, and Immunity

Volumn 25, Issue 3, 2011, Pages 429-433

  Liu, Jie ^a   Li, Junyan ^a   Li, Tao ^a   Wang, Ti ^a   Li, You ^a   Zeng, Zhen ^a   Li, Zhiqiang ^a   Chen, Peng ^a   Hu, Zhiwei ^a   Zheng, Lingqing ^a   Ji, Jue ^a   Lin, He ^a   Feng, Guoyin ^b   Shi, Yongyong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Bipolar disorder; CTLA 4 gene; Major depressive disorder; Schizophrenia

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLELE; ARTICLE; BIPOLAR DISORDER; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC HYPERMUTATION;

ALLELES; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SCHIZOPHRENIA;

EID: 79551688322     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.024     Document Type: Article

References (39)

1. Berrettini W.H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry 2000, 48:531-538.
2. Bramon E., Sham P.C. The common genetic liability between schizophrenia and bipolar disorder: a review. Curr. Psychiatry Rep. 2001, 3:332-337.
3. Brandon N.J., Millar J.K., Korth C., Sive H., Singh K.K., Sawa A. Understanding the role of DISC1 in psychiatric disease and during normal development. J. Neurosci. 2009, 29:12768-12775.
4. Brunet J.F., Denizot F., Luciani M.F., Roux-Dosseto M., Suzan M., Mattei M.G., Golstein P. A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987, 328:267-270.
5. Cardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M., McGuffin P. A twin-study of genetic relationships between psychotic symptoms. Am. J. Psychiatry 2002, 159:539-545.
6. Cazzullo C.L., Scarone S., Grassi B., Vismara C., Trabattoni D., Clerici M., Clerici M. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:947-957.
7. Chubb J.E., Bradshaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC locus in psychiatric illness. Mol. Psychiatry 2008, 13:36-64.
8. Craddock N., O'Donovan M.C., Owen M.J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder and mixed (or 'schizoaffective') psychoses. Schizophr. Bull. 2009, 35:482-490.
9. Gooding R., Riches P., Dadian G., Moore J., Gore M. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Br. J. Cancer 1995, 72:452-455.
10. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 2010, 15:1016-1022.
11. Gribben J.G., Freeman G.J., et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 1995, 92:811-815.
12. Jones A.L., Holliday E.G., Mowry B.J., McLean D.E., McGrath J.J., Pender M.P., Greer J.M. CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia. Brain Behav. Immun. 2009, 23:347-350.
13. Jun T.Y., Pae C.U., Chae J.H., Bahk W.M., Kim K.S. Polymorphism of CTLA-4 gene for major depression in the Korean population. Psychiatry Clin. Neurosci. 2001, 55:533-537.
14. Jun T.Y., Pae C.U., Chae J.H., Bahk W.M., Kim K.S., Han H. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population. Psychiatry Res. 2002, 110:19-25.
15. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity?. Genes Immun. 2000, 1:170-184.
16. Krummel M.F., Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996, 183:2533-2540.
17. Li, Y., Zhao, Q., Wang, T., Liu, J., Li, J., Li, T., Zeng, Z., Feng, G., He, L., Shi, Y. 2010. Association study between GNB1L and three major mental disorders in Chinese Han populations. Psychiatry Res [Epub ahead of print].
18. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., He L., Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysisbio-x.cn). Cell Res. 2009, 19:519-523.
19. Licinio J., Mastronardi C., Wong M.L. Pharmacogenomics of neuroimmune interactions in human psychiatric disorders. Exp. Physiol. 2007, 92:807-811.
20. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpé S., Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 1998, 32:9-15.
21. Loftis J.M., Huckans M., Morasco B.J. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol. Dis. 2010, 37:519-533.
22. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
23. McGuffin P., Katz R. The genetics of depression and manicdepressive disorder. Br. J. Psychiatry 1989, 155:294-304.
24. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 2003, 60:497-502.
25. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet.. 2000, 9:1415-1423.
26. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. 1997, 159:2994-2999.
27. Müller N., Hofschuster E., Ackenheil M., Mempel W., Eckstein R. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 1993, 17:713-730.
28. Müller N., Riedel M., Ackenheil M., Schwarz M.J. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J. Biol. Psychiatry 2000, 1:173-179.
29. Müller N., Schwarz M.J. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev. Neurother. 2006, 6:1017-1038.
30. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: asystematic quantitative review. Biol. Psychiatry 2008, 63:801-808.
31. Rothermundt M., Arolt V., Weitzsch C., Eckhoff D., Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol. Psychiatry 1996, 40:1294-1297.
32. Scalapino K.J., Daikh D.I. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol. Rev. 2008, 223:143-155.
33. Schwarz M.J., Chiang S., Müller N., Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav. Immun. 2001, 15:340-370.
34. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
35. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005, 65:1493-1520.
36. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16.
37. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
38. Wilke I., Arolt V., Rothermundt M., Weitzch C., Hornberg M., Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246:279-284.
39. Wilson D.R., Warise L. Cytokines and their role in depression. Perspect. Psychiatr. Care 2008, 44:285-289.